Trials / Completed
CompletedNCT00942604
A Multicenter Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel When Used to Treat Actinic Keratoses (AKs) on the Non Head Locations
A Multi-center, Randomized, Parallel Group, Double-blind, Vehicle-controlled Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel, 0.05%, In Patients With Actinic Keratoses on Non-head Locations (REGION-Ib)
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 203 (actual)
- Sponsor
- Peplin · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether topical application of PEP005 is effective for the treatment of actinic keratoses.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | PEP005 (ingenol mebutate) Gel | two day treatment |
| DRUG | Vehicle gel | two day treatment |
Timeline
- Start date
- 2009-07-01
- Primary completion
- 2009-10-01
- Completion
- 2009-10-01
- First posted
- 2009-07-21
- Last updated
- 2015-03-06
- Results posted
- 2012-03-19
Locations
17 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00942604. Inclusion in this directory is not an endorsement.